Optical Biopsy in Gynecological Surgery
NCT04154683
· ctgov
completed
- Enrollment
- 80
- Start
- 2020-06-29
- Completion
- 2026-08-28
- Last updated
- 2026-09-10
- Has results
- False
- Countries
- France
Conditions
Interventions
-
Cellvizio®
DEVICE
use of the Cellvizio® optical biopsy
Eligibility criteria
Inclusion Criteria:
* Women aged 18 years or more
* Informed and signed consent
* Planned surgery under laparoscopy and included in the list below:
* unilateral or bilateral salpingectomy
* hysterectomy
* ovariectomy
* surgery of endometriosis
* surgery for cancer of the cervix, endometrium, ovaries
Exclusion Criteria:
* Interview revealing disorder entailing unacceptable risk of postoperative complications: coagulation disorder, immune system disorder, evolutive disease, etc.
* Pregnancy or desire of pregnancy during the study period, breastfeeding
* Hypersensitivity to Fluorescein or any of its excipients
* History of life-threatening reaction during angiography
* Known allergic reactions and hypersensitivity
* Severe asthma, heart and / or lung disease, diabetes
* Person on beta-blocker treatment
* Inability to understand information provided
* Not covered by a national health insurance scheme, prisoner or under administrative supervision
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of ClinicalTrials.gov / U.S. National Library of Medicine
Courtesy of ClinicalTrials.gov / U.S. National Library of Medicine